CompoAtlas

HUIYAN REBALANCE JINSOFlex Capsule

HUIYAN REBALANCE JINSOFlex Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL25036119TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
HY REBALANCE TCM SDN. BHD.
Manufacturer
WAN YEEN TRADING SDN. BHD.
Registration period starting
2025-03-04
Published validity end
2030-03-04

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Pueraria lobataPueraria lobata[100 mg,500 mg]Not identified
Paeonia lactiflora (Alba)Paeonia lactiflora (Alba)[60 mg,500 mg]Not identified
Curcuma longaCurcuma longa[40 mg,500 mg]Not identified
Spatholobus suberectusSpatholobus suberectus[40 mg,500 mg]Not identified
Gynostemma pentaphyllumGynostemma pentaphyllum[30 mg,500 mg]Not identified
Corydalis yanhusuoCorydalis yanhusuo[30 mg,500 mg]Not identified
Chaenomeles speciosaChaenomeles speciosa[30 mg,500 mg]Not identified
Cinnamomum cassiaCinnamomum cassia[20 mg,500 mg]Not identified
Poria cocosPoria cocos[20 mg,500 mg]Not identified
Angelica sinensisAngelica sinensis[20 mg,500 mg]Not identified
Notopterygium incisumNotopterygium incisum[20 mg,500 mg]Not identified
Leonurus heterophyllusLeonurus heterophyllus[20 mg,500 mg]Not identified
Morus albaMorus alba[20 mg,500 mg]Not identified
Liquidambar formosanaLiquidambar formosana[10 mg,500 mg]Not identified
Ligusticum chuanxiongLigusticum chuanxiong[10 mg,500 mg]Not identified
Saposhnikovia divaricataSaposhnikovia divaricata[10 mg,500 mg]Not identified
Ligusticum sinenseLigusticum sinense[10 mg,500 mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[10 mg,500 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Pueraria lobata[100 mg,500 mg],Paeonia lactiflora (Alba)[60 mg,500 mg],Curcuma longa[40 mg,500 mg],Spatholobus suberectus[40 mg,500 mg],Gynostemma pentaphyllum[30 mg,500 mg],Corydalis yanhusuo[30 mg,500 mg],Chaenomeles speciosa[30 mg,500 mg],Cinnamomum cassia[20 mg,500 mg],Poria cocos[20 mg,500 mg],Angelica sinensis[20 mg,500 mg],Notopterygium incisum[20 mg,500 mg],Leonurus heterophyllus[20 mg,500 mg],Morus alba[20 mg,500 mg],Liquidambar formosana[10 mg,500 mg],Ligusticum chuanxiong[10 mg,500 mg],Saposhnikovia divaricata[10 mg,500 mg],Ligusticum sinense[10 mg,500 mg],Glycyrrhiza uralensis[10 mg,500 mg]
Valid until
2030-03-04
Registration date
2025-03-04
Published description
NATURAL PRODUCT
Licence holder
HY REBALANCE TCM SDN. BHD.
Producer
WAN YEEN TRADING SDN. BHD.
Published name
HUIYAN REBALANCE JINSOFlex Capsule
Published reference
2024091716016T
Registration number
MAL25036119TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL25036119TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Curcuma longa
    Read the warning, when it applies and the studies cited

    TURMERIC - CURCUMA LONGA - Oral

    Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 26 September 2025

    Turmeric -CURCUMA LONGA - Topical

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

  • Cinnamomum cassia
    Read the warning, when it applies and the studies cited

    CASSIA - CINNAMOMUM AROMATICUM

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Appetite loss; Digestive disturbances/Indigestion; Traditional Chinese Medicine claims.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Blumenthal et al. 2000; WHO 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Gardner and McGuffin 2013; Brinker 2010).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day.

    Do not use if you are pregnant (PPRC 2020; Brinker 2010; BHC 2006; Chen and Chen 2004; Blumenthal 2000, 1998).

    6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Traditional Chinese Medicine claims.

    Do not use if you have excess heat, blood heat or deficiency, or yin-deficient fire (PPRC 2020; Bensky et al. 2004; Chen and Chen 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Gardner and McGuffin 2013; Blumenthal 2000; WHO 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 May 2025

  • Angelica sinensis
    Read the warning, when it applies and the studies cited

    DONG QUAI - ANGELICA SINENSIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid exposure to the sun (NS 2021; Thorne 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (NS 2021; WHO 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line